Tuesday, 27 November 2018

Roche buys U.S. biotech Jecure in race for liver disease drugs

Swiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat fatty liver disease.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)